Table 2 Patients switched to ETV with a detectable viral load
From: Etravirine use in clinical practice: 48-week data from a single centre cohort
VL< 50 copies/ml | 12 weeks (n = 52) | 24 weeks (n = 44) | 36 weeks (n = 33) | 48 weeks (n = 25) |
|---|---|---|---|---|
Intention to treat | 65% | 73% | 70% | 76% |
On treatment | 71% | 84% | 79% | 90% |